Fact CheckerSign in

NCT06964724Active, not recruiting

NeVa Retrospective Comparative SR Study

NeVa International, MulTi-center, Retrospective cOmparative Stent Retriever Study

Source: ClinicalTrials.gov · Last updated 31 Mar 2026

Brief summary (registry, in English)

To compare safety and effectiveness of NeVa Stent Retriever (SR) to Control SR in the treatment of stroke caused by large vessel occlusion. The main questions it aims to answer are: How do recanalization rates for NeVa SR compare with those of the Control SR? How does NeVa SR safety compare with Control SR safety?

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
800 (estimated)
First submitted
18 Apr 2025
Start date
15 Jun 2025
Primary completion date
1 Jun 2026
Lead sponsor
Vesalio
Diseases
Stroke
NCT number
NCT06964724

What you commit to

  • Study type: Observational
  • Planned participants: 800
  • From 15 Jun 2025 to the primary completion date, 1 Jun 2026
  • 5 sites in 5 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • First line contact aspiration alone or non-study device as first-line device

Who the study is looking for

  • Treatment during the enrollment period
  • Age ≥18
  • Baseline modified Thrombolysis in Cerebral Infarction (mTICI) score ≤ 1
  • Pre-stroke modified Rankin score (mRS) of 0 or 1
  • Internal Carotid Artery (ICA), Middle Cerebral Artery (first segment M1/ second segment M2), basilar artery or vertebral artery occlusion
  • National Institutes of Health Stroke Scale (NIHSS) score ≥ 8 and ≤ 25
  • Thrombectomy procedure initiated within 8h of Time Last Known Well (TLKW)
  • Intravenous Tissue Plasminogen Activator (IV-tPA) failed, given within 3h of TLKW, or ineligibility for thrombolytic drug

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital Español de Mendoza
Coordinator of this site? Confirm its status
MendozaArgentinaUnknown status
CHU Liège
Coordinator of this site? Confirm its status
LiègeBelgiumUnknown status
UK Munster
Coordinator of this site? Confirm its status
MünsterGermanyUnknown status
Republican Vilnius University Hospital
Coordinator of this site? Confirm its status
VilniusLithuaniaUnknown status
İstanbul Aydrn Üniversitesi
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.